The Medical Technology Empire Conquering Hospitals and Research Facilities the World Over
By: Adam Surplice
This high-level disinfection machine is hitting medical facilities the world over… here’s how you can profit from the rising trend.
Infection prevention is the name of the game, and one company currently stands to be in a league of its own. One company currently stands to be the gold-standard benchmark. All from a patented disinfection device. Which is good news for them, given the rising trend across the world geared towards “… stricter ultrasound probe reprocessing…” guidelines. And it can also be good news for you.
At this very moment, the company in question is moving units like you would not believe. In the way of +252% installations from the first half of the 2015 financial year to December of last year—and that’s having barely tapped into the Asia-Pacific market.
What’s more, their “razor and blade” business model is set to bring them a lot more revenue, beyond the basic delivery and plug-in-set-up. The initial purchase of each machine comes at a price-point of $10,000 USD to $15,000 USD; which, even accounting for multiple devices being housed within any given facility, is a fairly standard figure. Where the true genius of this company’s business model lies, and where the real money comes in, has to do with the four to five-year contract customers are locked into after the initial purchase.
That’s four to five years of paying the company for the “… patented and exclusive…” consumable products, not to mention the bespoke servicing, which costs somewhere between $3,000 USD and $5,000 USD per round. In straight bottom-line numbers, this comes to a total gross profit margin of almost 90%, and over the life of a single system, consumables will make up around 70% of the total revenue. Imagine all those numbers stacking up over time. Now imagine all those numbers stacking up over time—for you.
As with any growing enterprise, this exponential growth means they’re open to investments.
That’s where you come in.
The time to act is now. This is your chance to profit from the future of medicine.
Want to find out more? Enter your e-mail before for a FREE stock report to get you investing TODAY:
This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. For more information about The Motley Fool see our Financial Services Guide. All returns cited are hypothetical and based on the percentage change between the stock price at the time of recommendation and the current or sell price (if the position has been closed) at the time of publication. Brokerage, taxes and any other associated costs are not taken into account. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. Performance figures are not intended to be a forecast and The Motley Fool does not guarantee the performance of, or returns on any investment. Any money back guarantee is strictly limited to the subscription price paid for the product.